On Friday, ArcelorMittal (NYSE: MT ) will release its latest quarterly results. The key to making smart investment decisions on stocks reporting earnings is to anticipate how they'll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise. That way, you'll be less likely to make an uninformed knee-jerk reaction to news that turns out to be exactly the wrong move.
As a major player in the steel industry, ArcelorMittal has struggled due to the slowdown in the global economy and in construction and infrastructure activity around the world. But despite those pressures, the steel giant has plans to get back to its growth path. Let's take an early look at what's been happening with ArcelorMittal over the past quarter and what we're likely to see in its quarterly report.
Hot Construction Companies To Invest In Right Now: ViewPoint Financial Group Inc.(VPFG)
ViewPoint Financial Group, Inc. operates as the holding company for ViewPoint Bank, which provides financial services for consumers and businesses. Its deposit products include checking, savings, money market, demand accounts, and certificates of deposit. The company?s loan portfolio comprises real estate loans, such as one-to four-family, commercial construction, and home equity loans, as well as commercial real estate loans for office buildings, retail centers, light industrial facilities, warehouses, and multifamily properties; consumer loans, including new and used automobile loans, recreational vehicle loans, loans secured by savings deposits, and unsecured consumer loans; and commercial non-mortgage loans, including loans to finance business working capital, commercial vehicles, and equipment, as well as lines of credit. It also offers brokerage services for the purchase and sale of non-deposit investment and insurance products through a third party brokerage arrang ement. As of March 31, 2011, the company operated 23 community bank offices in the Dallas/Fort Worth Metroplex and 13 loan production offices located in Texas, Oklahoma, and Ohio. ViewPoint Financial Group, Inc. is headquartered in Plano, Texas.
Hot Construction Companies To Invest In Right Now: Worthington Energy Inc (WGAS)
Worthington Energy, Inc. (Worthington), formerly Paxton Energy, Inc., incorporated July 30, 2004, is an oil and gas exploration and production company with assets in Texas and in the Gulf of Mexico. Worthington�� assets in Texas consist of a minority working interest in limited production and drilling prospects in the Cooke Ranch area of La Salle County, Texas, and Jefferson County, Texas, all operated by Bayshore Exploration L.L.C. (Bayshore). The Company�� assets in the Gulf of Mexico consist of a leasehold working interests in certain oil and gas leases located offshore from Louisiana, upon which no drilling or production has commenced as of December 31, 2011, and a 10.35% interest in the recently drilled I-1 well and a 2% royalty interest in 14,400 acres in the Mustang Island Tract 818. On March 27, 2012, it acquired certain assets from Black Cat Exploration & Production, LLC.
In Texas, the Company has working interests ranging from 4% to 31.75% (net revenue interests ranging from 3% to 23.8125%) in the various wells. In the Gulf of Mexico it has a 70% leasehold working interest, with a net revenue interest of 51.975%, of certain oil and gas leases in the Vermillion 179 tract and 10.35% interest in the recently drilled I-1 well and a 2% royalty interest in 14,400 acres in the Mustang Island Tract 818. As of December 31, 2011, it had one producing well that generated average total monthly net revenue.
The Mustang Island 818-L Field, located in the Kleberg County waters of the Gulf of Mexico, is a field re-habilitation project targeting bypassed or only partially produced gas-condensate. Total production from the wells within the seismic coverage was 125.6 billion cubic feet. In January 2011, the Hercules Offshore 205 jack-up rig was contracted to re-enter the I-Well on the Mustang License Area. The oil and gas leases are located in the VM 179, which is in the shallow waters of the Gulf of Mexico offshore from Louisiana. VM 179 is at 85 inches water depth approximately ! 46 miles offshore Louisiana in the Gulf of Mexico.
Best Gold Stocks To Watch Right Now: Endocyte Inc.(ECYT)
Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases. The company uses its proprietary technology to create novel small molecule drug conjugates (SMDCs) and companion imaging diagnostics. Its SMDCs target receptors that are over-expressed on diseased cells, relative to healthy cells. The company?s principal SMDC product candidate, EC145, has been evaluated in a randomized Phase II clinical trial for the treatment of women with platinum-resistant ovarian cancer, and it also completed a Phase II single-arm clinical trial for pre-treated non-small cell lung cancer. Its preclinical development products include EC0489 and EC0225, which are in Phase I clinical trial for the treatment of solid cancer tumors; EC17 that has completed Phase I clinical trial for the treatment of solid cancer tumors; EC0531, a tubulysin conjugate to treat solid tumors; and EC0746 and EC0565 foliate receptors for the reduction o f inflammation. The company?s products under development also comprise EC20, a proprietary companion imaging diagnostic product for the identification of folate receptor in cancer patients; EC1069 for prostate cancer therapy; and EC0652 that is in early clinical trials for use as a companion imaging diagnostic for SMDCs. Endocyte, Inc. was founded in 1995 and is headquartered in West Lafayette, Indiana.
Advisors' Opinion:- [By Rougemont]
Endocyte, Inc. (ECYT) is a biotechnology company based in Indiana. These shares have traded in a range between $3.02 to $14.80 in the last 52 weeks. The 50-day moving average is $6.35, and the 200-day moving average is $10.13. ECYT is estimated to lose about $1.46 per share in 2011, and post a loss of about $1.21 per share for 2012. In the product development pipeline, Endocyte has a candidates for cancer and inflammatory diseases. The lead candidate is "EC145," which targets the folate receptor in certain cancers. ECYT shares plunged recently when disapointing results were announced with a potential ovarian cancer treatment. Endocyte was added to the NASDAQ Biotechnology Index in late 2011. A director recently bought 125,000 shares, which supports the view that this stock is oversold and a bargain.
No comments:
Post a Comment